IL201627A - Process for Preparation of 6 - {4 - [3 - ((r) -2 - Methyl-Pyrrolidine-1-Il) -Propoxy] -Phenyl} -2H-Pyridazine-3-On - Google Patents

Process for Preparation of 6 - {4 - [3 - ((r) -2 - Methyl-Pyrrolidine-1-Il) -Propoxy] -Phenyl} -2H-Pyridazine-3-On

Info

Publication number
IL201627A
IL201627A IL201627A IL20162709A IL201627A IL 201627 A IL201627 A IL 201627A IL 201627 A IL201627 A IL 201627A IL 20162709 A IL20162709 A IL 20162709A IL 201627 A IL201627 A IL 201627A
Authority
IL
Israel
Prior art keywords
methylpyrrolidine
tartrate
methyl
phenyl
propoxy
Prior art date
Application number
IL201627A
Other languages
English (en)
Hebrew (he)
Other versions
IL201627A0 (en
Original Assignee
Cephalon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon Inc filed Critical Cephalon Inc
Publication of IL201627A0 publication Critical patent/IL201627A0/en
Publication of IL201627A publication Critical patent/IL201627A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Catalysts (AREA)
IL201627A 2007-05-03 2009-10-19 Process for Preparation of 6 - {4 - [3 - ((r) -2 - Methyl-Pyrrolidine-1-Il) -Propoxy] -Phenyl} -2H-Pyridazine-3-On IL201627A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92735607P 2007-05-03 2007-05-03
PCT/US2008/005702 WO2008137087A1 (en) 2007-05-03 2008-05-02 Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof

Publications (2)

Publication Number Publication Date
IL201627A0 IL201627A0 (en) 2010-05-31
IL201627A true IL201627A (en) 2014-06-30

Family

ID=39688886

Family Applications (1)

Application Number Title Priority Date Filing Date
IL201627A IL201627A (en) 2007-05-03 2009-10-19 Process for Preparation of 6 - {4 - [3 - ((r) -2 - Methyl-Pyrrolidine-1-Il) -Propoxy] -Phenyl} -2H-Pyridazine-3-On

Country Status (14)

Country Link
EP (1) EP2152669A1 (enExample)
JP (1) JP5698887B2 (enExample)
KR (1) KR20100017565A (enExample)
CN (1) CN101679237A (enExample)
AU (1) AU2008248168B2 (enExample)
BR (1) BRPI0810330A2 (enExample)
CA (1) CA2686033A1 (enExample)
EA (1) EA019031B1 (enExample)
IL (1) IL201627A (enExample)
MX (1) MX2009011787A (enExample)
NZ (1) NZ580948A (enExample)
UA (1) UA99913C2 (enExample)
WO (1) WO2008137087A1 (enExample)
ZA (1) ZA200907643B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ574873A (en) 2006-07-25 2012-03-30 Cephalon Inc Pyridazinone derivatives as h3 inhibitors
US8383657B2 (en) 2007-12-21 2013-02-26 Abbott Laboratories Thiazolylidine urea and amide derivatives and methods of use thereof
ES2479440T3 (es) * 2008-01-30 2014-07-24 Cephalon, Inc. Derivados de piridazina sustituidos que tienen actividad antagonista de histamina H3
US10259794B2 (en) * 2014-12-23 2019-04-16 Cephalon, Inc. Methods for preparing fused bicyclic 2, 4-diaminopyrimidine derivatives
KR20210057032A (ko) * 2018-09-07 2021-05-20 사노피 메틸 6-(2,4-디클로로페닐)-5-[4-[(3s)-1-(3-플루오로프로필)피롤리딘-3-일]옥시페닐]-8,9-디히드로-7h-벤조[7]아눌렌-2-카르복실레이트의 염 및 이의 제조 방법

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3329974A1 (de) 1983-08-19 1985-02-28 Bayer Ag, 5090 Leverkusen Herstellung von hydrierten nitrilkautschuken
DE3433392A1 (de) 1984-09-12 1986-03-20 Bayer Ag, 5090 Leverkusen Hydrierung nitrilgruppenhaltiger ungesaettigter polymerer
FR2714849B1 (fr) 1994-01-13 1996-04-05 Inst Francais Du Petrole Procédé de préparation d'un catalyseur d'hydrogénation soluble en phase liquide organique.
DE4403479A1 (de) 1994-02-04 1995-08-10 Basf Ag Verfahren zur Herstellung von Hydroxylammoniumsalzen
WO2004024707A2 (en) * 2002-09-16 2004-03-25 Abbott Laboratories Process for preparing amine type substituted benzofurans
US7153889B2 (en) 2002-11-12 2006-12-26 Abbott Laboratories Bicyclic-substituted amines as histamine-3 receptor ligands
US8110519B2 (en) 2004-03-08 2012-02-07 Japan Science & Technology Agency Polymer-supported metal cluster composition
US7145005B2 (en) 2004-05-12 2006-12-05 Abbott Laboratories 2-(6-{2-[(2R)-2-Methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyridazin-3-one salts and their preparation
CN1960727B (zh) 2004-06-02 2011-02-16 霍夫曼-拉罗奇有限公司 用作组胺-3受体的配体的萘衍生物
US8158652B2 (en) 2004-12-01 2012-04-17 Msd K.K. Substituted pyridone derivative
DE602005026169D1 (de) 2004-12-17 2011-03-10 Janssen Pharmaceutica Nv Tetrahydroisochinolinverbindungen zur behandlung von zns-erkrankungen
CA2595157A1 (en) 2005-01-21 2006-07-27 Schering Corporation Imidazole and benzimidazole derivatives useful as histamine h3 antagonists
EP1866293A1 (en) 2005-03-31 2007-12-19 UCB Pharma, S.A. Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses
GB0514812D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
WO2007048595A1 (en) 2005-10-27 2007-05-03 Ucb Pharma, S.A. Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
US7897634B2 (en) 2006-02-09 2011-03-01 Athersys, Inc. Pyrazoles for the treatment of obesity and other CNS disorders
WO2007099423A1 (en) 2006-03-02 2007-09-07 Pfizer Products Inc. 1-pyrrolidine indane derivatives as histamine-3 receptor antagonists
US20090163482A1 (en) 2006-03-13 2009-06-25 Mchardy Stanton Furst Tetralines antagonists of the h-3 receptor
WO2008005338A1 (en) 2006-06-29 2008-01-10 Arena Pharmaceuticals, Inc. Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
NZ574873A (en) * 2006-07-25 2012-03-30 Cephalon Inc Pyridazinone derivatives as h3 inhibitors

Also Published As

Publication number Publication date
ZA200907643B (en) 2014-03-26
KR20100017565A (ko) 2010-02-16
AU2008248168B2 (en) 2013-03-21
BRPI0810330A2 (pt) 2014-10-14
MX2009011787A (es) 2009-11-13
UA99913C2 (ru) 2012-10-25
AU2008248168A1 (en) 2008-11-13
CA2686033A1 (en) 2008-11-13
EA019031B1 (ru) 2013-12-30
JP5698887B2 (ja) 2015-04-08
EP2152669A1 (en) 2010-02-17
JP2010526142A (ja) 2010-07-29
NZ580948A (en) 2011-04-29
CN101679237A (zh) 2010-03-24
EA200971019A1 (ru) 2010-04-30
WO2008137087A1 (en) 2008-11-13
IL201627A0 (en) 2010-05-31

Similar Documents

Publication Publication Date Title
US20100121055A1 (en) Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof
JP6491393B2 (ja) ヒストン脱アセチル化酵素6阻害剤としての1,3,4−オキサジアゾール誘導体化合物及びこれを含有する薬剤学的組成物
JP6392888B2 (ja) ヒストン脱アセチル化酵素6阻害剤としての新規化合物およびこれを含む薬剤学的組成物
AU2006275870B2 (en) Novel 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders
CN111770918B (zh) Trpc6的抑制剂
IL201627A (en) Process for Preparation of 6 - {4 - [3 - ((r) -2 - Methyl-Pyrrolidine-1-Il) -Propoxy] -Phenyl} -2H-Pyridazine-3-On
EA009903B1 (ru) Бициклические [3.1.0] производные в качестве ингибиторов переносчиков глицина
JP2024512428A (ja) 抗ウイルス化合物
CA2791431A1 (en) Derivatives of aminoindanes, their preparation and their application in therapeutics
JP2023533783A (ja) ヒストン脱アセチル化酵素6阻害剤としての新規な構造の化合物およびこれを含む薬剤学的組成物
WO2007102567A1 (ja) 3,4-ジ置換ピロリジン誘導体の製造方法及び製造中間体
AU2007329808A1 (en) 1,5-diphenyl-3-benzylamino-1,5-dihydropyrrolidin-2-one as CB1 receptor modulators
CN114728177A (zh) 作为Kv1.3钾Shaker通道阻滞剂的芳基杂二环化合物
CN113677673A (zh) Trpc6的抑制剂
ES2561834T3 (es) Naftiridonas y quinolonas 7-amino alquilidenil-heterocíclicas
WO2004029048A1 (en) Heterocyclic substituted piperazines for the treatment of schizophrenia
JP2010526142A5 (enExample)
CN101142180A (zh) 作为组胺h3受体拮抗剂的吡咯烷衍生物
WO2006082872A1 (ja) 1-(ピペリジン-4-イル)-1h-インドール誘導体
KR20230164136A (ko) Kv1.3 칼륨 셰이커 채널 차단제로서의 아릴 헤테로시클릭 화합물
AU2005252178B2 (en) Histamine H3 receptor agents, preparation and therapeutic uses
ZA200700950B (en) Pyrrole derivatives, their preparation and their therapeutic use
AU2006316609A1 (en) Modulators of the H3 receptor useful for the treatment of disorders related thereto
WO2002089803A1 (fr) Composition d'ionophorese
RU2817736C1 (ru) Новые соединения в качестве ингибитора гистондеацетилазы 6 и фармацевтическая композиция, содержащая их

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees